Screening and Intervention of MASLD in Children

NANot yet recruitingINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2027

Conditions
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseChildren
Interventions
DIAGNOSTIC_TEST

Fibroscan test

Perform Fibroscan testing on the study subjects every six months.

BEHAVIORAL

Nutrition guidance

Each family will be matched with a nutritionist, who will provide daily online dietary guidance for parents and students during the first 21 days, followed by weekly sessions thereafter.

BEHAVIORAL

Increase physical activity

Increase physical activity time in and out of school by professional sports trainer.

OTHER

Health education

Knowledge of healthy lifestyle will be delivered in various forms such as health lectures, brochures, posters, etc.

Trial Locations (1)

315010

The First Affiliated Hospital of Ningbo University, Ningbo

All Listed Sponsors
collaborator

Peking University

OTHER

lead

Ningbo No. 1 Hospital

OTHER

NCT06905795 - Screening and Intervention of MASLD in Children | Biotech Hunter | Biotech Hunter